These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18030046)

  • 1. Accurate grading of 3 synchronous liposarcomas assessed by PET-CT in a single patient.
    Reddy MP; Sangster GP; Takalkar AM; Heldmann M; Zhang RD; Lilien DL
    Clin Nucl Med; 2007 Dec; 32(12):937-9. PubMed ID: 18030046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Round cell liposarcoma presenting as an FDG-positive primary with an FDG-negative retroperitoneal metastasis: a pitfall for F-18 FDG PET/CT imaging.
    Rakheja R; Makis W; Nahal A; Alabed YZ; Abikhzer G; Probst S; Hickeson M
    Clin Nucl Med; 2011 Dec; 36(12):e213-6. PubMed ID: 22064114
    [No Abstract]   [Full Text] [Related]  

  • 3. PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma.
    Suzuki R; Watanabe H; Yanagawa T; Sato J; Shinozaki T; Suzuki H; Endo K; Takagishi K
    Ann Nucl Med; 2005 Dec; 19(8):661-70. PubMed ID: 16444991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intense FDG Uptake in Well-Differentiated Inflammatory Liposarcoma of the Retroperitoneum.
    Zhao Q; Dong A; Zuo C; Fang Y
    Clin Nucl Med; 2024 Jul; 49(7):685-687. PubMed ID: 38598478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imaging.
    Charest M; Singnurkar A; Hickeson M; Novales JA; Derbekyan V
    Clin Nucl Med; 2008 Jul; 33(7):455-8. PubMed ID: 18580228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Histologic Subtype and FNCLCC Grade by SUVmax Measured on
    Li CP; Liu DN; Zhou NN; Tian XY; Wang Z; Liu BN; Hao CY
    Contrast Media Mol Imaging; 2021; 2021():7191363. PubMed ID: 33505228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of soft tissue lesions suspicious for liposarcoma by F18-deoxyglucose (FDG) positron emission tomography (PET).
    Schwarzbach MH; Dimitrakopoulou-Strauss A; Mechtersheimer G; Hinz U; Willeke F; Cardona S; Attigah N; Strauss LG; Herfarth C; Lehnert T
    Anticancer Res; 2001; 21(5):3609-14. PubMed ID: 11848531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between pathology and image characteristics of retroperitoneal liposarcoma].
    Xiao WB; Wang ZM; Xu SL
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):235-7. PubMed ID: 15949426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
    Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
    J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant transformation of retroperitoneal inflammatory pseudotumor to undifferentiated high-grade pleomorphic sarcoma on FDG PET/CT.
    Ho L; Sheth S; Wassef H; Henderson R
    Clin Nucl Med; 2012 May; 37(5):484-5. PubMed ID: 22475899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extrarenal Retroperitoneal Angiomyolipoma Masquerading as Retroperitoneal Liposarcoma : A Report of Two Cases].
    Yamamoto R; Inoue T; Numakura K; Tsuruta H; Maeno A; Saito M; Narita S; Tsuchiya N; Satoh S; Habuchi T
    Hinyokika Kiyo; 2016 Jun; 62(6):317-22. PubMed ID: 27452495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer.
    Kitajima K; Murakami K; Yamasaki E; Hagiwara S; Fukasawa I; Inaba N; Kaji Y; Sugimura K
    Ann Nucl Med; 2008 Feb; 22(2):103-9. PubMed ID: 18311534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall].
    Yamamoto H; Sugimoto S; Miyoshi K; Yamamoto H; Soh J; Yamane M; Toyooka S; Oto T; Miyoshi S
    Kyobu Geka; 2014 Jan; 67(1):4-8. PubMed ID: 24743405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.
    Kostakoglu L; Hardoff R; Mirtcheva R; Goldsmith SJ
    Radiographics; 2004; 24(5):1411-31. PubMed ID: 15371617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grading liposarcomas with PET using [18F]FDG.
    Adler LP; Blair HF; Williams RP; Pathria MN; Makley JT; Joyce MJ; al-Kaisi N; Miraldi F
    J Comput Assist Tomogr; 1990; 14(6):960-2. PubMed ID: 2229575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
    Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
    J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-18 FDG PET/CT imaging in a case of primary choriocarcinoma in the retroperitoneum.
    Cimarelli S; Deshayes E; Mognetti T; Biron P; Desuzinges C; Rivoire M; Giammarile F
    Clin Nucl Med; 2009 Jul; 34(7):449-51. PubMed ID: 19542954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.